Evidence map›Paper›PMID 24152989›Full record

ArticleToxins2013

Assessment of the functional regions of the superantigen staphylococcal enterotoxin B.

Lily Zhang, Thomas J Rogers

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lily ZhangCenter for Inflammation, Translational and Clinical Lung Research, Temple University School of Medicine, 3500 N. Broad Street, Philadelphia, PA 19140, USA. rogerst@temple.edu.
Thomas J Rogers
Temple University · US

Funding

Opioid &Chemokine Receptor Interactions Relative to HIVR01DA014230 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2001 to 2016
$5.0M
Opioid Modulation of Inflammatory Monocyte Activity Involved in HIV SusceptibilitR01DA025532 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ROGERS, THOMAS J · 2008 to 2012
$1.5M
IMMUNOSUPPRESSIVE ACTION OF STAPHYLOCOCCAL ENTEROTOXINSR01AI023828 · NIAID · TEMPLE UNIVERSITY · PI ROGERS, THOMAS J · 1987 to 1996
–
NIAID NIH HHS AI23828NIDA NIH HHS R01 DA014230NIDA NIH HHS R01 DA025532
6 · The paper itself

Abstract

The functional activity of superantigens is based on capacity of these microbial proteins to bind to both the β-chain of the T cell receptor (TcR) and the major histocompatibility complex (MHC) class II dimer. We have previously shown that a subset of the bacterial superantigens also binds to a membrane protein, designated p85, which is expressed by renal epithelial cells. This binding activity is a property of SEB, SEC1, 2 and 3, but not SEA, SED, SEE or TSST. The crystal structure of the tri-molecular complex of the superantigen staphylococcal enterotoxin B (SEB) with both the TcR and class II has previously been reported. However, the relative contributions of regions of the superantigen to the overall functional activity of this superantigen remain undefined. In an effort to better define the molecular basis for the interaction of SEB with the TcR β-chain, we report studies here which show the comparative contributions of amino- and carboxy-terminal regions in the superantigen activity of SEB. Recombinant fusion proteins composed of bacterial maltose-binding protein linked to either full-length or truncated toxins in which the 81 N-terminal, or 19 or 34 C-terminal amino acids were deleted, were generated for these studies. This approach provides a determination of the relative strength of the functional activity of the various regions of the superantigen protein.

Indexed as

AnimalsCell LineEnterotoxinsEscherichia coli ProteinsHistocompatibility Antigens Class IIMiceMice, Inbred C3HPeriplasmic Binding ProteinsProtein BindingRecombinant Fusion ProteinsSuperantigensT-Lymphocytesenterotoxin B, staphylococcalEnterotoxinsEscherichia coli ProteinsHistocompatibility Antigens Class IIMalE protein, E coliPeriplasmic Binding ProteinsRecombinant Fusion ProteinsSuperantigens

Identifiers

PMID24152989
PMCPMC3813916
OpenAlexW2043511361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.